🇺🇸 FDA
Patent

US 11382918

Methods for treating Huntington's Disease

granted A61KA61K31/444A61K31/519

Quick answer

US patent 11382918 (Methods for treating Huntington's Disease) held by PTC THERAPEUTICS, INC. expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/444, A61K31/519, A61K31/5377, A61K31/551